MMV established a consortium with the Clinton Health Access Initiative (CHAI) and the Malaria Consortium (MC) to implement the MMV-led Improving Severe Malaria Outcomes (ISMO) project. This project, funded by UNITAID, aimed to improve the availability of injectable artesunate (Inj AS) for the treatment of severe malaria in six high-burden African countries: Cameroon, Ethiopia, Kenya, Malawi, Nigeria, and Uganda.
In September 2016, the project came to a successful close having achieved the following:
- More than 90% of severe malaria cases across the six countries are now treated with Inj AS in preference to quinine;
- More than 18,000 health-care workers across 2,082 facilities were trained to administer Inj AS.
Read more about injectable artesunate.
Issue 7 - February 2016
Issue 6 - November 2015
Issue 5 - July 2015
Issue 4 - April 2015
Issue 3 - January 2015
Issue 2 - October 2014
Issue 1 - May 2014